Pharmaceutical Executive
Episodes
Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs
26 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, Novartis plans to eliminate 550 positions at a major Swiss site, the FDA authorizes the first gene therap...
Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan
25 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, Novo Nordisk faces market pressure after a late-stage trial setback, Moderna takes out a $1.5 billion loa...
Pharmaceutical Executive Daily: Tesaro and AnaptysBio's Legal Battle
24 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, learn how Tesaro is suing AnaptysBio over alleged contract breaches, Flagship Pioneering and Valo Health ...
Pharmaceutical Executive Daily: Novartis' North Carolina Manufacturing Hub
21 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, learn how Abbott is acquiring Exact Sciences in a major diagnostics deal, Novartis is building a new manu...
Pharmaceutical Executive Daily: Moderna's $140 Million Manufacturing Investment
20 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, learn how Moderna is expanding its manufacturing footprint in Massachusetts, GSK is advancing new researc...
Pharmaceutical Executive Daily: FDA's Approval of Epkinly
19 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, learn how Novo Nordisk is launching an introductory offer for Wegovy and Ozempic, AbbVie and Genmab gain ...
Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure
18 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily learn how Novo Nordisk is restructuring leadership to enhance scientific and commercial alignment, ABL Bio...
Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval
13 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, WeightWatchers plans to offer Novo Nordisk’s oral Wegovy pending FDA approval, FDA unveils a new Plausi...
Pharmaceutical Executive Daily: Dr. Richard Pazdur Appointed as Director CDER
13 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, Richard Pazdur is named director of FDA’s Center for Drug Evaluation and Research, Pfizer strengthens f...
Pharmaceutical Executive Daily: AstraZeneca Becomes UK's Largest Stock
12 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, AstraZeneca surpasses Shell to become the UK’s largest listed company, Basel intensifies efforts to att...
Pharmaceutical Executive Daily: Wegovy Shows Potential to Treat MASH Patients
11 Nov 2025
Contributed by Lukas
Raising Biomarker Awareness
10 Nov 2025
Contributed by Lukas
Dr. Jaspal Singh explains some of the barriers that prevent cancer patients from getting biomarker testing early in their treatment journey.
Pharmaceutical Executive Daily: FDA Approves Darzalex Faspro
10 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Darzalex Faspro for adults with high-risk smoldering multiple myeloma, t...
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1's to TrumpRX
07 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly and Novo Nordisk’s plans to bring their leading weight-loss medications to the Trump...
Pharmaceutical Executive Daily: Novo Nordisk's Amended Acquisition Proposal
06 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s amended proposal to acquire Metsera, the State of Texas’ attempt to block Ken...
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
05 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Kimberly-Clark’s $48.7 billion acquisition of Kenvue, Cencora’s $1 billion investment to str...
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
04 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Pfizer’s lawsuits against Metsera and Novo Nordisk over alleged intellectual property infringe...
Pharmaceutical Executive Daily: George Tidmarsh Resigns from FDA
03 Nov 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s plan to submit its oral GLP-1 candidate for FDA priority review, the departure of ...
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
31 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s unsolicited proposal to acquire Metsera, renewed legal action against Tylenol’...
Pharmaceutical Executive Daily: Thermo Fisher's $8.8 Billion Acquisition of Clario Holdings
30 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli Lilly’s partnership wit...
Pharmaceutical Executive Daily: Lilly and NVIDIA Create AI Supercomputer
29 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge...
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
28 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon s...
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
27 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the FDA approval of Bayer’s Lynkuet for menopausal hot flashes, new research suggesting Ozempi...
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization
24 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the emergence of TrumpRx and its implications for direct-to-consumer drug commercialization, new...
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
23 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover market reaction to Novo Nordisk’s recent board shake-up, MJH Life Sciences’ acquisition of B...
Pharmaceutical Executive Daily: Novo Nordisk's Board Shake-Up
22 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to reject a petition ca...
Pharmaceutical Executive Daily: Merck's $70 Billion Investment
21 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Merck’s $70 billion expansion of U.S. operations, the FDA’s latest approvals for Novo Nordis...
Pharmaceutical Executive Daily: FDA's National Priority Voucher Program
20 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the FDA’s creation of a new National Priority Voucher Program, the market reaction to Presiden...
Shifting Focus in Autoimmune Diseases
20 Oct 2025
Contributed by Lukas
Artax Biopharma’s CEO Rob Armstrong explains recent shifts in autoimmune R&D before discussing his leadership style.
Pharmaceutical Executive Daily: EMD Serono’s Agreement with US Government
17 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we explore how antibody-drug conjugate collaborations are moving beyond oncology into autoimmune diseases...
Pharmaceutical Executive Daily: Rethinking Workforce Development
16 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we explore how pharma leaders are rethinking workforce development at the executive level, the industry’...
Pharmaceutical Executive Daily: Johnson & Johnson Separating Its Orthopedics Unit
15 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we explore Johnson & Johnson’s plan to separate its orthopaedics division into a standalone company, th...
Pharmaceutical Executive Daily: Direct-To-Consumer Trends
14 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Takeda’s new multi-year research collaboration with Nabla Bio, how tariff and pricing pressure...
Advancing Neuroscience and Rare Disease Innovation
14 Oct 2025
Contributed by Lukas
Acadia Pharmaceuticals’ CEO Catherine Owen Adams discusses the current climate in R&D and details her leadership style.
Pharmaceutical Executive Daily: Policy Whiplash
13 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Ypsomed’s new North Carolina manufacturing site, how pharma leaders are maintaining strategic ...
Pharmaceutical Executive Daily: Most Favored Nation Order's Evolving Landscape
10 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Bristol Myers Squibb’s $1.5 billion acquisition of Orbital Therapeutics, ongoing legal and mar...
Pharmaceutical Executive Daily: Why DSCSA Compliance is Only The Beginning
09 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Johnson & Johnson’s Simponi for pediatric ulcerative colitis, why DSCS...
Pharmaceutical Executive Daily: Amgen Launches New Direct-To-Consumer Platform
08 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we explore why medical AI success depends on more than algorithms, Amgen’s launch of its new direct-to-...
Pharmaceutical Executive Daily: FDA Lifts Clinical Hold on NUZ-001
07 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the FDA lifting its clinical hold on Neurizon Therapeutics’ lead program Nuz-001, the agency’...
Pharmaceutical Executive Daily: Updated Vaccine Recommendations
06 Oct 2025
Contributed by Lukas
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pha...
Pharmaceutical Executive Daily: FDA's new Fast-Track Review
03 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the FDA’s new fast-track review program for U.S.-made generics, Novartis’ FDA approval of Rh...
Pharmaceutical Executive Daily: President Trump Pauses Tariff Plan
02 Oct 2025
Contributed by Lukas
Stay informed on key pharmaceutical news, including tariff updates, FDA shutdown risks, and insights from recent cell and gene therapy reviews.
Pharmaceutical Executive Daily: Novo Nordisk Resubmits BLA for Awiqli
01 Oct 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s resubmission of its BLA for Awiqli, the FDA’s approval of Kedrion’s Qivigy ...
Pharmaceutical Executive Daily: September 30, 2025
30 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover AbbVie’s new API manufacturing site in Illinois, AstraZeneca’s plan to harmonize its global ...
Pharmaceutical Executive Daily: September 29, 2025
29 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the impact of Novo Nordisk layoffs on its hometown in Denmark, GSK’s appointment of Luke Miels...
Pharmaceutical Executive Daily: September 26, 2025
26 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the White House’s push for a Most Favored Nation drug pricing model, the FDA’s approval of E...
Pharmaceutical Executive Daily: September 25, 2025
25 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Glenmark’s billion-dollar exclusive licensing deal with Hengrui, Harmony Biosciences’ trial ...
Pharmaceutical Executive Daily: September 24, 2025
24 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover the market reaction to Trump’s Tylenol–autism claim, the FDA’s complete response letter to...
Pharmaceutical Executive Daily: September 23, 2025
23 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover GSK’s supplemental application to update the label for Leucovorin, the FDA’s complete respon...
Pharmaceutical Executive Daily: September 22, 2025
22 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Biogen’s acquisition of Alcyone Therapeutics to expand its drug delivery solutions, the FDA’...
Pharmaceutical Executive Daily: September 19, 2025
19 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover how pharma companies can scale AI pilots into enterprise-wide value, GSK’s plan to invest $30 ...
Pharmaceutical Executive Daily: September 18, 2025
18 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock Bio’s $50 million Series ...
Pharmaceutical Executive Daily: September 17, 2025
17 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Lilly’s orforglipron as a prime candidate for FDA fast-track approval, Merck and Daiichi Sanky...
Pharmaceutical Executive Daily: September 16, 2025
16 Sep 2025
Contributed by Lukas
Pharmaceutical Executive Daily: September 15, 2025
15 Sep 2025
Contributed by Lukas
Pharmaceutical Executive Daily: September 12, 2025
12 Sep 2025
Contributed by Lukas
Today's episode covers the president’s call to lower drug costs for patients, the compliance and operational pressures facing pharmaceutical manufac...
Pharmaceutical Executive Daily: September 11, 2025
11 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Lundbeck’s restructuring affecting more than 600 international employees, Novo Nordisk’s glo...
Pharmaceutical Executive Daily: September 9, 2025
09 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we explore strategies to strengthen pharma sales messaging, the role of AI-driven simulations in field re...
Pharmaceutical Executive Daily: September 8, 2025
08 Sep 2025
Contributed by Lukas
Pharmaceutical Executive Daily: September 5, 2025
05 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we will recap the top stories of the week, exploring the current state of the GLP-1 market, review major ...
Pharmaceutical Executive Daily: September 4, 2025
04 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover political pressure on Moderna and Novavax to release COVID-19 vaccine evidence, a deep dive into...
Pharmaceutical Executive Daily: September 3, 2025
03 Sep 2025
Contributed by Lukas
In today’s Pharmaceutical Executive Daily, we cover Pfizer’s response to political pressure over COVID-19 vaccine safety data, Cheryl Reicin’s o...
The Rx for High-Performance Leadership: Cutting Through the Chaos
22 Aug 2025
Contributed by Lukas
In a turbulent era for biopharma, leadership demands clarity, resilience, and adaptability. In this candid podcast conversation with Pharm Exec, Ken B...
Pharmaceutical Executive Weekly:CSL Cuts Jobs, Pfizer’s Sickle Cell Setback, and Eli Lilly Expands Zepbound Access
21 Aug 2025
Contributed by Lukas
In this week’s Pharmaceutical Executive Weekly, we cover CSL’s decision to cut 15% of its U.S. workforce and close 22 plasma centers, Pfizer’s P...
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
14 Apr 2025
Contributed by Lukas
LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, discusses strategies to address underrepresentation in phase III psoriasis tr...
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
24 Mar 2025
Contributed by Lukas
In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses: The impact of tariffs on the pharmaceut...
The Misinformation Maze: Navigating Public Health in the Digital Age
11 Mar 2025
Contributed by Lukas
In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses: The threat of misinformation ...
Navigating Distrust: Pharma in the Age of Social Media
18 Feb 2025
Contributed by Lukas
In this episode of the Pharmaceutical Executive Podcast, CEO and Founder of Sooth, Ian Baer, is back to discuss: The growing distrust in social med...
Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
10 Feb 2025
Contributed by Lukas
In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient ...
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
30 Jan 2025
Contributed by Lukas
In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses...
Key Findings of the NIAGARA and HIMALAYA Trials
08 Nov 2024
Contributed by Lukas
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, A...
Fake Weight Loss Drugs: Growing Threat to Consumer Health
25 Oct 2024
Contributed by Lukas
UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss: Counterfeit weight loss drugs (particularly fake Oze...
A Different Approach to Dermatology Care
23 Sep 2024
Contributed by Lukas
Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs i...
Beyond the Birthrate: The Societal Costs of Maternal Morality
06 Sep 2024
Contributed by Lukas
In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusse...
Empty Shelves, Urgent Solutions
05 Aug 2024
Contributed by Lukas
Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts and the main factors that are contributing to the closures of ...
The Weight-Loss Gold Rush: Legal and Regulatory Implications
11 Jul 2024
Contributed by Lukas
Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses: Top legal and regulatory concerns for investors considering when fin...
Healthcare Marketing Strategies for Reaching Diverse Audiences
14 May 2024
Contributed by Lukas
Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&...
A Decade in the Anti-Obesity Arena
30 Apr 2024
Contributed by Lukas
Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access ...
Fierce Females in the Life Science Space
28 Mar 2024
Contributed by Lukas
In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with fem...
Gen-Z Influence on Pharma M&A
14 Mar 2024
Contributed by Lukas
Ian Baer, Founder and Chief Soothsayer, Sooth, discusses their recent data and research about some massive behavioral shifts occurring across Gen-Z, a...
Recent Licensing Agreement Poised to Advance Company ADC
26 Jan 2024
Contributed by Lukas
Jingsong Wang, Chairman of Nona Biosciences, discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and...
Cell and Gene Therapy Check-in 2024
18 Jan 2024
Contributed by Lukas
Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum ...
Reshaping Pharmacovigilance in the age of AI
04 Jan 2024
Contributed by Lukas
Sameer Lal, Sr. Vice President, Enterprise Medical Solutions at Indegene, discusses findings from their new study about Reshaping Pharmacovigilance in...
Patient Centric Diabetes Care
14 Dec 2023
Contributed by Lukas
Dr. Julien Boisdron, Global Head of OneMedical / Chief Medical Officer Roche Diabetes Care, discusses the current standard for diabetes care, the impo...
DCT Opportunities in Clinical Research
26 Oct 2023
Contributed by Lukas
Edward Triebell, Commercial Executive Director for MRN Technologies, discusses the biggest digital trends in clinical research right now, how COVID-19...
New FDA SaMD Guidance Will Bring Monumental Changes to Industry
12 Oct 2023
Contributed by Lukas
David Klein, co founder and CEO of Click Therapeutics, discusses the new FDA SaMD guidance, the clear differences between companion apps and SaMD, an...
Venture Creation Firm Reveals Strategies For Launching New Companies & Forming Collaborations
28 Sep 2023
Contributed by Lukas
In this exclusive Pharm Exec Podcast episode with Paul Biondi, executive partner at Flagship Pioneering (the venture creation firm behind Moderna and ...
Avoiding Commercialization Pitfalls for CGTs
14 Sep 2023
Contributed by Lukas
Commercialization is a tough road to navigate even for the most established bio/pharmaceutical therapies. But as cell and gene therapies (CGTs) contin...
Ethical AI Practices
31 Aug 2023
Contributed by Lukas
Gerald Kierce, co founder and CEO of Trustible and Andrew Gamino-Cheong, the company's CTO and co founder, delve into the realm of artificial intellig...
Drug Pricing Challenges and Navigating The IRA
17 Aug 2023
Contributed by Lukas
How to price a bio/pharmaceutical drug is one of the most complex topics for pharmaceutical executives, as there are many factors to consider. Alice V...
Pharma Marketing in the Age of AI: A New Era Begins
03 Aug 2023
Contributed by Lukas
In this podcast, Sharlene Jenner, vice president of engagement strategy at Abelson Taylor and professor of AI and personalization for digital marketer...
Transforming Cancer Care: Data, AI, and Patient-Centered Care
20 Jul 2023
Contributed by Lukas
In this podcast, Mohit Manrao, the SVP and head of US oncology at AstraZeneca, shares his journey from growing up in Northern India with aspirations o...
AI Frontiers: Navigating the Risks, Rewards, and Regulations
06 Jul 2023
Contributed by Lukas
Welcome to a riveting episode of the Pharm Exec podcast, where we dive headfirst into the transformative world of AI in healthcare with Sharlene Jenne...
Listening is the Key to Good Leadership
22 Jun 2023
Contributed by Lukas
We all know that the pharma industry is about people—bettering the lives of others through good research, life-changing pharmaceuticals, and keeping...
The Trust Imperative: Defining and Building Trust in Pharma
08 Jun 2023
Contributed by Lukas
This Pharma 50 companion episode delves into the vital topic of trust within the pharmaceutical industry. Morton Nielsen, senior partner for the life ...
Emerging Potential: Changing Lives One Story, One Therapeutic at a Time
25 May 2023
Contributed by Lukas
The 2023 Emerging Pharma Leaders share with Meg Rivers, managing editor of Pharmaceutical Executive, and the editorial team what makes a good leader, ...
Drug Approvals And Launches From A Legal Perspective
11 May 2023
Contributed by Lukas
Launching a drug and receiving approvals—whether it’s in the U.S. or globally—is challenging to navigate. It’s a process that often takes year...
Exploring Arcutis’s Patient - Centric Dermatology Innovations
27 Apr 2023
Contributed by Lukas
In this episode of the Pharmaceutical Executive Podcast, we dive into a conversation with Frank Watanabe, president and CEO of Arcutis, a medical derm...
Tackling Reproductive Health And Fertility Care
13 Apr 2023
Contributed by Lukas
Elizabeth (Beth) Garner, chief scientific officer for Ferring Pharmaceuticals, speaks with Meg Rivers, managing editor, about: 1) her journey into the...
Repurposing Drugs - How One Doctor Saved His Own Life And Hopes To Save Others
30 Mar 2023
Contributed by Lukas
Two companies join forces to unlock the hidden potential in existing drugs to save lives suffering from rare diseases. In 2010, Dr. David Fajgenbaum, ...